Group One Trading
RVMD icon

Group One Trading’s Revolution Medicines RVMD Stock Holding History

Group One Trading’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
119,400
+112,500
+1,630% +$11.4M 0.02% 747
2025
Q4 		$550K Sell
6,900
-56,200
-89% -$3.69M ﹤0.01% 3411
2025
Q3 		$2.95M Sell
63,100
-13,400
-18% -$525K 0.01% 1950
2025
Q2 		$2.81M Buy
76,500
+66,900
+697% +$2.57M 0.01% 1817
2025
Q1 		$339K Sell
9,600
-6,700
-41% -$272K ﹤0.01% 3467
2024
Q4 		$713K Sell
16,300
-12,000
-42% -$606K ﹤0.01% 2882
2024
Q3 		$1.28M Buy
28,300
+27,200
+2,473% +$1.18M ﹤0.01% 2102
2024
Q2 		$42.7K Sell
1,100
-40,700
-97% -$1.52M ﹤0.01% 4629
2024
Q1 		$1.35M Sell
41,800
-92,300
-69% -$2.74M 0.01% 1820
2023
Q4 		$3.85M Buy
134,100
+78,700
+142% +$1.89M 0.01% 1332
2023
Q3 		$1.53M Buy
55,400
+50,300
+986% +$1.49M 0.01% 1875
2023
Q2 		$136K Buy
5,100
+5,000
+5,000% +$123K ﹤0.01% 4311
2023
Q1 		$2.17K Buy
+100
New +$2.46K ﹤0.01% 6594
2022
Q3 		– Sell
-100
Closed -$2K – 8142
2022
Q2 		$2K Sell
100
-4,800
-98% -$93.4K ﹤0.01% 7430
2022
Q1 		$125K Buy
+4,900
New +$107K ﹤0.01% 5284

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Group One Trading's RVMD Position: Q1 2026 in Review

Group One Trading sold out of Revolution Medicines (RVMD) in Q1 2026, closing a stake of 40,145 shares — an estimated $4.05M sold.

Group One Trading first reported a position in RVMD in Q2 2022 and held it in 9 quarters. The position peaked at $3.2M in Q4 2025. 512 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Group One Trading reported no remaining Revolution Medicines position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 40,145 Revolution Medicines shares in Q1 2026, an estimated $4.05M.
  • Group One Trading first reported a position in Revolution Medicines in Q2 2022 and held it in 9 quarters.
  • Group One Trading's Revolution Medicines position peaked at $3.2M in Q4 2025.
  • 512 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.